News
News
- Arcutis to Advance Topical Roflumilast Foam (ARQ-154) into Phase 3 Development for the Treatment of Seborrheic Dermatitis
15:00 - GlobeNewswire - Adamis Pharmaceuticals Announces IND Submission to FDA for Tempol for the Treatment of COVID-19
15:00 - GlobeNewswire - Greater Cannabis Company Announces Retirement of Remaining Convertible Debt
14:57 - GlobeNewswire - RideShare Rental, Inc., Formerly YayYo, Inc., Announces HQ Office Move to Accommodate Accelerated Growth
14:50 - GlobeNewswire - Blueberries Medical Closes $1M Strategic Financing Led by a Leading Latin American Private Equity Group with Extensive International Cannabis Industry Expertise; Appoints Facundo Garretón as Chairman & Interim CEO
14:30 - GlobeNewswire - Chesapeake Gold Completes Acquisition of Alderley Gold Corp. Appointments of Directors and Officers
14:30 - Newsfile Corp - Interpace Biosciences Announces Third Quarter 2020 Financial and Business Results and Completion of $5 Million Bridge Loan
14:30 - GlobeNewswire - Ehave, Inc. Closes 20/20 Global Transaction, Mycotopia Therapy Now Operating as a Publicly Traded Company with Intent to Focus on Psychedelic Sector
14:30 - GlobeNewswire - TAOP Raises $2.0 Million To Accelerate Growth
14:30 - GlobeNewswire - Liquid Media Announces AGM Results and New Director
14:30 - GlobeNewswire
Real-time